Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05929469
Other study ID # 23-0396
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2, 2023
Est. completion date April 25, 2024

Study information

Verified date October 2023
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this initial pilot and feasibility study is to test different digital, behavioral weight loss approaches, with or without human support, using a sequential, multiple assignment, randomized trial (SMART) design. All participants in this pilot trial will receive a 3-month mobile health (mHealth) program. The dose of human support will vary by first- and second-line randomizations. The feasibility, acceptability, and preliminary outcomes for each of the treatment sequences will be assessed.


Description:

Ninety-nine adults, ages 18-65, with overweight or obesity, will be randomized in total. All participants will receive an mHealth program (App) for program duration that includes activity tracking with a Fitbit, weight tracking with a smart scale, and an app for diet tracking. At baseline, participants will be randomized to either a a) Fully Automated Kick-Off, or b) Human-Enhanced Kick-Off. "Early responders" will continue with to use App, alone. After 4 weeks, "early non-responders" in both arms will be re-randomized once to one of two augmented interventions with human support: Counseling or Check-In. Assessments will occur at baseline, 1 week, 4 weeks, and 3 months to explore feasibility, acceptability, and preliminary outcomes (weight, self-monitoring adherence, behavioral goal adherence).


Recruitment information / eligibility

Status Completed
Enrollment 99
Est. completion date April 25, 2024
Est. primary completion date April 25, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Current age: 18-65 years - Lives in North Carolina - Body mass index (BMI) of 27.5-45 kg/m^2 - Ability to read, write, and speak English - Ownership of iPhone with a data and texting plan - Ability to commit to the required counseling sessions (0-5 sessions, based on randomization) - Is not living a participant or staff member on this trial - Willingness to be randomized to any of the treatment sequences Exclusion Criteria: - Weight loss of more than 10 pounds in the last 6 months that was maintained - A history of weight loss surgery - Pre-existing medical condition(s) that prevent them from adhering to a supervised exercise routine - Have Type 1 Diabetes or are currently taking medicine for Type 2 Diabetes - Have recently been diagnosed or treated for cancer - Currently pregnant, pregnant within the past 6 months, or plan to become pregnant in the next 6 months - Report taking prescription or over the counter medication with a known impact on metabolism or weight - Report a history of an eating disorder - History of psychotic disorder or bipolar disorder, or have been hospitalized for depression or other psychiatric disorder within the past 12 months - History of alcohol or substance abuse - Current participation in another weight loss program that may interfere with participation in this study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
App
Participants will receive an mHealth program.
Fully Automated Kick-Off
As an orientation to the study, participants will receive a fully automated kick-off session.
Human-Enhanced Kick-Off
As an orientation to the study, participants will receive a kick-off session that includes time with a study interventionist.
Check-In
Participants will receive a check-in with a study interventionist.
Counseling
Participants will receive counseling from a study interventionist.

Locations

Country Name City State
United States University of North Carolina at Chapel Hill Chapel Hill North Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill Academy of Nutrition and Dietetics

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility- Rate of early nonresponse The rate of early response will be calculated as the number of individuals deemed "early responders" divided by the total number of participants randomized. 4 weeks
Primary Feasibility- Percentage of participants with missing data at 4 weeks The percentage of participants with missing data at 4 weeks will be calculated as the number of participants who do not complete the 4-week weight assessment divided by the total number of participants randomized. 4 weeks
Secondary Weight Change- Percent weight change from baseline to 3 months Percent weight change from baseline to 3 months will be calculated ((3 month weight - baseline weight)/100). Weight will be objectively measured on a scale in the participant's home. Baseline, 3 months
Secondary Weight Change- Percent weight change from baseline to 4 weeks Percent weight change from baseline to 4 weeks will be calculated ((4 week weight - baseline weight)/100). Weight will be objectively measured on a scale in the participant's home Baseline, 4 weeks
Secondary Weight Change- Percent weight change from 4 weeks to 3 months Percent weight change from 4 weeks to 3 months will be calculated ((3 month weight - 4 week weight)/100). Weight will be objectively measured on a scale in the participant's home 4 weeks, 3 months
Secondary Acceptability- Rate of attendance at human support sessions The rate of attendance at human support sessions will be calculated as the number of human sessions completed divided by the number of human sessions assigned. Up to 3 months
Secondary Acceptability- Attrition Attrition will be calculated as the number of intervention participants who did not complete 3-month weight measures divided by the number randomized to treatment. Up to 3 months
Secondary Acceptability- Overall program satisfaction rating Overall program satisfaction will be assessed using a single item, which asks participants to rate their overall satisfaction with the program on a 4-point Likert scale that ranges from "very dissatisfied" to "very satisfied," in which higher scores indicate greater levels of satisfaction. 3 months
Secondary Weighing Self-Monitoring Adherence Number of days of self-weighing over the 3 month period, measured by use of the scale in the participant's home. Baseline to 3 months (daily)
Secondary Dietary Self-Monitoring Adherence Number of days of complete dietary tracking summed over the 3-month study period, as measured by app use data. Baseline to 3 months (daily)
Secondary Physical Activity Self-Monitoring Adherence Number of days of physical activity tracking over the 3 month period, as measured by Fitbit tracker wear. Baseline to 3 months (daily)
Secondary Dietary Goal Adherence Number of days the participant met their daily calorie goal over the 3 month period, as measured by app data. Baseline to 3 months (daily)
Secondary Activity Goal Adherence Number of days the participant met their active minutes goal over the 3 month period, as measured by app data. Baseline to 3 months (daily)
Secondary Change in Diet Change in daily caloric intake from baseline to 3 months, as measured using the self- administered National Cancer Institute's Automated Self- Administered 24-hour Recall (ASA-24), a 24-hour recall that is self-administered on one day at each timepoint. Baseline, 3 months
Secondary Change in Physical Activity Change in physical activity from baseline to 3 months, as measured using the Paffenbarger Physical Activity Questionnaire (PPAQ). The PPAQ assesses amount of planned and lifestyle associated physical activity performed during a typical week. The PPAQ consists of three components: (1) stair climbing, (2) walking, and (3) sports and recreation. Participants report the frequency and duration of physical activity in the past week. Scoring yields energy expenditure from physical activity per week (kcal/kg/week). Higher scores translate into greater energy expenditure per week (i.e.,better outcome). Range is 0 - no theoretical maximum. Baseline, 3 months
Secondary Change in Motivation Change in motivation from baseline to 4 weeks and 3 months, as measured using the Treatment Self-Regulation Questionnaire (TSRQ). The TSRQ assesses autonomous and controlled motivation for weight management. Six items assess autonomous motivation and six assess controlled motivation using a 7 point Likert scale, in which 1 corresponds to "not at all true" and 7 corresponds to "very true." Items will be averaged to produce scores for autonomous motivation and controlled motivation ranging from 1-7. Higher values on each sub-scale indicate greater levels of that type of motivation. A Relative Autonomous Index (RAI) score will be separately calculated by subtracting the controlled motivation score from the autonomous motivation score. The range of possible RAI scores is -6 to 6. Baseline, 1 week, 4 weeks, 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2